Articles with public access mandates - Henrik DitzelLearn more
Not available anywhere: 9
Review
Anti-human CD73 monoclonal antibody inhibits metastasis formation in human breast cancer by inducing clustering and internalization of CD73 expressed on the surface of cancer cells
MG Terp, KA Olesen, EC Arnspang, RR Lund, BC Lagerholm, HJ Ditzel, ...
The Journal of Immunology 191 (8), 4165-4173, 2013
Mandates: Danish Council for Technology and Innovation, Danish Council for Independent …
Review
Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy
D Elias, H Vever, AV Laenkholm, MF Gjerstorff, CW Yde, AE Lykkesfeldt, ...
Oncogene 34 (15), 1919-1927, 2015
Mandates: Danish Council for Independent Research, Danish Council for Strategic Research
Review
High CDK6 protects cells from fulvestrant-mediated apoptosis and is a predictor of resistance to fulvestrant in estrogen receptor–positive metastatic breast cancer
CL Alves, D Elias, M Lyng, M Bak, T Kirkegaard, AE Lykkesfeldt, HJ Ditzel
Clinical cancer research 22 (22), 5514-5526, 2016
Mandates: Danish Council for Independent Research
Review
Quantitative proteomics of primary tumors with varying metastatic capabilities using stable isotope‐labeled proteins of multiple histogenic origins
RR Lund, MG Terp, AV Lænkholm, ON Jensen, R Leth‐Larsen, HJ Ditzel
Proteomics 12 (13), 2139-2148, 2012
Mandates: Danish Council for Independent Research, Danish National Research Foundation
Review
Epigenetic reprogramming of pericentromeric satellite DNA in premalignant and malignant lesions
NH Brückmann, CB Pedersen, HJ Ditzel, MF Gjerstorff
Molecular Cancer Research 16 (3), 417-427, 2018
Mandates: US National Institutes of Health, Danish Council for Independent Research
Review
Limited SP17 expression within tumors diminishes its therapeutic potential
MF Gjerstorff, HJ Ditzel
Tissue antigens 80 (6), 523-527, 2012
Mandates: Danish Council for Independent Research
Review
Gene expression alterations associated with outcome in aromatase inhibitor-treated ER+ early-stage breast cancer patients
KG Thomsen, MB Lyng, D Elias, H Vever, AS Knoop, AE Lykkesfeldt, ...
Breast cancer research and treatment 154, 483-494, 2015
Mandates: Danish Council for Independent Research
Review
Application of proteomics in the study of rodent models of cancer
MG Terp, HJ Ditzel
PROTEOMICS–Clinical Applications 8 (9-10), 640-652, 2014
Mandates: Danish Council for Independent Research
Review
SSX2 promotes the formation of a novel type of intranuclear lamin bodies
S Traynor, ND Jakobsen, MF Ebbesen, SN Bennedsen, S Johansen, ...
The International Journal of Biochemistry & Cell Biology 142, 106121, 2022
Mandates: Danish Council for Independent Research
Available somewhere: 78
Review
CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women with Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial
MM Regan, B Leyland-Jones, M Bouzyk, O Pagani, W Tang, R Kammler, ...
Journal of the National Cancer Institute 104 (6), 441-451, 2012
Mandates: US National Institutes of Health
Review
Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study
AR Kodahl, MB Lyng, H Binder, S Cold, K Gravgaard, AS Knoop, ...
Molecular oncology 8 (5), 874-883, 2014
Mandates: Danish Council for Independent Research
Review
IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel
ZN Wee, SMJM Yatim, VK Kohlbauer, M Feng, JY Goh, Y Bao, PL Lee, ...
Nature communications 6 (1), 8746, 2015
Mandates: A*Star, Singapore
Review
Co-activation of STAT3 and YES-associated protein 1 (YAP1) pathway in EGFR-mutant NSCLC
I Chaib, N Karachaliou, S Pilotto, J Codony Servat, X Cai, X Li, ...
JNCI: Journal of the National Cancer Institute 109 (9), djx014, 2017
Mandates: US National Institutes of Health, National Natural Science Foundation of …
Review
Chromosome 1q21. 3 amplification is a trackable biomarker and actionable target for breast cancer recurrence
JY Goh, M Feng, W Wang, G Oguz, SMJM Yatim, PL Lee, Y Bao, TH Lim, ...
Nature medicine 23 (11), 1319-1330, 2017
Mandates: A*Star, Singapore, National Medical Research Council, Singapore
Review
Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer
K Jacobsen, J Bertran-Alamillo, MA Molina, C Teixidó, N Karachaliou, ...
Nature communications 8 (1), 410, 2017
Mandates: US National Institutes of Health, Villum Foundation, Government of Spain …
Review
Fyn is an important molecule in cancer pathogenesis and drug resistance
D Elias, HJ Ditzel
Pharmacological research 100, 250-254, 2015
Mandates: Danish Council for Independent Research
Review
Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis
R Leth-Larsen, MG Terp, AG Christensen, D Elias, T Kühlwein, ...
Molecular medicine 18, 1109-1121, 2012
Mandates: Danish Council for Independent Research
Review
Downregulation of antigen presentation-associated pathway proteins is linked to poor outcome in triple-negative breast cancer patient tumors
MH Pedersen, BL Hood, HC Beck, TP Conrads, HJ Ditzel, R Leth-Larsen
Oncoimmunology 6 (5), e1305531, 2017
Mandates: Danish Council for Independent Research, Innovation Fund Denmark
Review
Hypoxia induces HIF1α-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapy
S Ma, Y Zhao, WC Lee, LT Ong, PL Lee, Z Jiang, G Oguz, Z Niu, M Liu, ...
Nature communications 13 (1), 4118, 2022
Mandates: A*Star, Singapore, National Medical Research Council, Singapore, National …
Review
AXL targeting abrogates autophagic flux and induces immunogenic cell death in drug-resistant cancer cells
ML Lotsberg, K Wnuk-Lipinska, S Terry, TZ Tan, N Lu, L Trachsel-Moncho, ...
Journal of Thoracic Oncology 15 (6), 973-999, 2020
Mandates: US National Institutes of Health, Research Council of Norway, Cancer …
Publication and funding information is determined automatically by a computer program